OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025
Article content
Article content
What:
OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1's Principal, Real World Evidence. The poster focuses on the linkage between Glucagon-like Peptide 1 Receptor Agonists (GLP-1s) and Suicidal Ideation (SI). Consistent with other findings and despite warnings on the label, there was no significant increase in SI prevalence after GLP-1 initiation.
Article content
When:
The poster session will be held at ISPOR 2025 on Wednesday, May 14, from 4:00 – 7:00 PM, with a discussion period from 6:00 – 7:00 PM.
Article content
Key Findings:
Amid growing scrutiny of GLP-1 receptor agonists (used in diabetes and obesity), OM1's real-world study finds no significant change in suicidal ideation (SI) following treatment initiation across both therapeutic populations.
Article content
Why It Matters:
GLP-1s indicated for obesity feature a package label warning for suicidal ideation, whereas those indicated for diabetes do not. This research adds to the growing body of evidence exploring whether this warning may present an unnecessary obstacle to treatment and a potential barrier to equitable access to healthcare for a long stigmatized population.
Article content
Suicidal ideation is often undercoded or missing entirely in claims-based datasets. By applying natural language processing (NLP) to unstructured clinician notes, OM1's study captures a richer, more nuanced view of patient mental health. This study reinforces the role of AI and real-world data (RWD) in advancing pharmacovigilance and public health safety.
Article content
About OM1:
OM1 is pioneering cutting-edge healthcare innovation through its insights-driven technology and data. It specializes in personalized medicine, evidence generation, and real-world evidence (RWE) research powered by next-generation AI platforms, deep longitudinal data, and globally recognized thought leadership. OM1 is led by a diverse group of scientists, engineers, researchers, and clinicians with over 30 years of experience in RWE.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
4 hours ago
- CTV News
CTV National News: Summer camps takes precautions against measles
Watch Parents are being told to check their children's measles vaccination status as summer camps hope to prevent cases. Allison Hurst reports.
Globe and Mail
5 hours ago
- Globe and Mail
WNP Launches All-in-One Hyaluronic Acid Skincare Set, Pioneering a "3-Step Scientific Skincare Method"
Culver City, California--(Newsfile Corp. - June 22, 2025) - Skincare brand WNP officially launched the "All-in-One Hyaluronic Acid Skincare Set" on its website, introducing its original "Three-Step Scientific Skincare Method." The set integrates five key skincare steps - cleansing, hydration, repair, brightening, and early-stage anti-aging - into a comprehensive skincare system based on four core innovations: nano-delivery, HTAC thermal water dynamics, 4D hyaluronic acid, and microencapsulation technology. This set offers a streamlined solution for everyday skincare needs. To view an enhanced version of this graphic, please visit: Four Key Innovations Nano-Liposome Delivery WNP utilizes nano-liposome technology to reduce Ceramide NP particle size to below 100 nm, enabling targeted delivery to the basal layer of the stratum corneum. Lab tests show it helps fill intercellular lipid gaps and reduce transepidermal water loss, offering industry-leading repair benefits for sensitive and barrier-damaged skin. HTAC Thermal Decomposition Water Dynamics WNP's toner features Italian patented HTAC technology, which protects red algae and recombinant collagen activity. Tests show it boosts natural hyaluronic acid production by 124% and cellular mitochondrial activity by 229%. 4D Hyaluronic Acid Multi-Layer Hydration Based on Bloomage Biotech's 4D hyaluronic acid formulation, four molecular weights of hyaluronic acid penetrate from the epidermis to the dermis. Combined with a water-in-oil lamellar emulsion structure, this provides deep, lasting hydration. Microencapsulated Time-Release Salicylic Acid Salicylic acid is microencapsulated for sustained release of active ingredients, delivering gentle exfoliation while minimizing irritation. Ideal for daily use on sensitive or combination-oily skin. Five Steps, One Streamlined Routine Gentle Cleansing: A non-soap amino acid cleanser with pH 5.5-6, refined through 45℃ natural crystallization to remove excess emulsifiers. Fine foam gently purifies without residue. Soothing & Hydration: A serum-texture toner that forms a water film on contact. Functions as both mist and toner for instant moisture. Targeted Hydration: 3% Hyaluronic Acid Capsules, a TikTok bestseller, delivers precise hydration without pilling. Brighten & Even: A matrix of niacinamide, SymWhite®377, and vitamin C derivatives to block melanin transfer and fade oxidized spots. Early Anti-Aging: Patented recombinant collagen, triple peptides, and multiple ceramides to rebuild elasticity and visibly firm skin within 28 days. Brand Vision "With this launch, WNP merges cutting-edge nano-delivery with a multi-dimensional hyaluronic hydration system to redefine what 'minimalist skincare' can mean," said WNP's Chief Product Spokesperson-Dr. Emily. "We believe skincare is shifting from ingredient stacking to true tech-enabled performance-and this launch is the clearest expression of that evolution." About WNP WNP (Wake Nature Perfection) is a science-driven skincare brand based in Asia, rooted in the philosophy of precision skincare. It integrates top-tier dermatological research with global innovations in active ingredients. As an industry innovator, WNP has introduced multiple "first-of-its-kind" technologies in both domestic and international markets, committed to delivering safe, effective, and targeted skincare solutions. For more information, please visit
CBC
16 hours ago
- CBC
U.S. science funding uncertainty reshapes grad school choices for Canadians
Social Sharing After graduating with a bachelor degree in mathematics from the University of Waterloo, Kareem Alfarra had hopes of continuing his studies in the United States. The American schools he looked at were better funded and had more opportunities than those in Canada, he said, and he'd already connected with some professors he'd like to work with. Alfarra, 22, applied to nine American universities, hoping for options, but he ended up being waitlisted and rejected for all of them. Most of them told him informally that budget uncertainties in the U.S. were making it difficult for them to accept graduate students, he said. He says one school even told him that in any normal year, he would have been accepted. "I was on top of the wait list … and I would have loved to go," he told CBC. Rather than waiting to hear, Alfarra decided to accept an offer at the University of Toronto, citing the funding uncertainty and political instability of the U.S. "I was very angry with the situation knowing that perhaps a year earlier or a few years later I would've gotten in." While that's just one student's story, universities on both sides of the border say that uncertainty brought on by the Trump administration is reducing options and upending research opportunities for graduate students — including Canadians. 'Closing off career pathways' More than 10,000 Canadians went to graduate school in the U.S. last year, according to data from the Institute for International Education, with 40 per cent pursuing science and health degrees. But there are two key federal sources that U.S. universities rely on to fund their labs and take in graduate students — the National Science Foundation (NSF) and National Institutes of Health (NIH) — that have been frozen or cut by the Trump administration. It's been a back and forth battle, with cases before the courts, and it's unclear where things will land. But the uncertainty is enough for some universities to reduce their admissions, inevitably trickling down to Canadian applicants. WATCH | How Trump's freeze on health research funding might hurt Canadian science: Canadian scientists worry after Trump pauses federal health spending 5 months ago Duration 2:01 In a statement to the CBC, the American Association of Universities described the stakes. "Federal research funding cuts are actively closing off career pathways for all prospective doctoral students from across the world, including those from the United States and Canada," said Emily Miller, vice president for research and institutional policy at the association. "Universities make a significant financial commitment when they offer admission to an aspiring scientist or researcher — a commitment that is critical to student success and one they cannot meet without federal research support." A 'turbulent' landscape For 23 year old Canadian Jaeden Bardati, research funding was a big component in his decision to pursue his PhD in astrophysics at Caltech in Pasadena, Calif., two years ago. "Which is kind of ironic now," he said. on research and development in 2022; in the U.S., that figure was nearly 3.6 per cent in the same year. Bardati would ultimately like to be where the top researchers in his field are, which historically had been the U.S., he says, but that may change. Budget uncertainty makes some researchers worried whether they can maintain their labs or pay the students that work in them. Bardati says some of his classmates have been encouraged to graduate early or to fund themselves to be able to stay. "The landscape is very turbulent … the word that's been used around here is turbulent," said Bardati, which makes it difficult for students and researchers to plan for the future. "They're essentially trying to find a new home at the moment. And they're thinking, 'should I go to Europe or should I go to Canada?'" U.S. students applying north Katie Marshall, associate professor in comparative physiology at the University in British Columbia, is already starting to see the effects of this shift. She's received five applications from U.S. students to come work in her lab. "Usually, I wouldn't start seeing these kinds of applications until the fall," she said. "It's definitely unusual." Marshall also noted that the funding cuts in the U.S. are affecting research in Canada, because cross-border collaboration means Canadian researchers have gotten funding from U.S. agencies. "With less money, there's just fewer spots [for graduate students]." "When I look at who I'm going to accept, I'm looking at their research experience, " said Marshall. "If I've got a great American student, it's really hard for me to say no." While Canada can't fill the gap left by the US, it is a good time to invest in Canadian research to create more opportunities, said Marshall, noting that there has been some recent increases already.
